Dr. Olatunji has served as chief pharmacy officer of Riverside Health since August 2025, providing executive leadership for pharmacy services across the integrated health system. Since her appointment, the system has expanded specialty pharmacy by 46% and infusion services by 51%, advanced innovative medication access strategies, and strengthened enterprisewide pharmacy operations to support high-quality, patient-centered care. Nationally, Dr. Olatunji serves on the 340B Health pharmacy services committee, where she chaired the 340B Health rebate workgroup and briefed congressional staff on the importance of the 340B program. She is also an active contributor to the American Society of Health-System Pharmacists’ Pharmacy Accountability Initiative 2030 and the Virginia Hospital & Healthcare Association’s 340B Workgroup. A sought-after speaker on pharmacy leadership, specialty pharmacy, infusion strategy and the evolving 340B landscape, Dr. Olatunji presents regularly at national conferences and industry forums. Throughout her career, she has championed innovation, interdisciplinary collaboration, and the strategic integration of pharmacy services to improve patient outcomes while creating sustainable value for the health systems she serves. Her leadership continues to position Riverside Health at the forefront of advancing pharmacy practice and delivering high-value, patient-centered care.
